Regen Biopharma Inc (RGBP) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Regen Biopharma Inc   (RGBP)

Regen Biopharma Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Regen Biopharma Inc in the third quarter 2026?
Due to the lack of equity, it was not possible to calculate Regen Biopharma Inc 's return on equity (ROE) in its third quarter 2026

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Dec 31 2025)
I. Quarter		 (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -2 -2 -2 -2 -1
Return On Equity (TTM) - - - - -
RGBP's Total Ranking # # # # #
Equity (TTM) in Millions -6 -5 -6 -6 -6
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to RGBP Management Effectiveness >> RGBP's 5 Years Annual ROE >> Compare RGBP ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





RGBP Annual Return On Equity (Sep 30 2025)
2025		 (Sep 30 2024)
2024		 (Sep 30 2023)
2023		 (Sep 30 2022)
2022		 (Sep 30 2021)
2021
Total Equity in Millions -6 -5 -5 -8 -13
Y / Y Equity Change - - - - -
Net Income in Millions -1 -1 1 2 -7
Y / Y Net Income Change - - -54.04 % - -
Return On Equity - - - - -

Back to RGBP Management Effectiveness >> RGBP's 5 Years Annual ROE >> Compare RGBP ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
RGBP's' Return on Equity at Yahoo Finance
RGBP's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for RGBP's Competitors
Subscribers only: Roe for Regen Biopharma Inc 's Suppliers
Subscribers only: Return On Equity for RGBP's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Eli Lilly And Company  92.54 %
Amgen Inc   89.32 %
Q32 Bio Inc   76.88 %
3m Company  76.55 %
Oramed Pharmaceuticals Inc  73.03 %
Tg Therapeutics Inc   72.30 %
Idexx Laboratories Inc  71.96 %
Elite Pharmaceuticals Inc   71.10 %
Zoetis Inc   68.87 %
Rallybio Corporation  68.56 %
Earth Science Tech Inc   66.17 %
Aurinia Pharmaceuticals Inc   59.00 %
Vaxart Inc   53.04 %
Qhslab Inc   51.21 %
Tenet Healthcare Corp  50.64 %
Nrc Health  48.29 %
Concentra Group Holdings Parent Inc   48.13 %
Bristol myers Squibb Company  46.65 %
Agilent Technologies inc   41.99 %
Eton Pharmaceuticals Inc   40.13 %
Adma Biologics Inc   39.59 %
Dexcom Inc   36.25 %
Transmedics Group Inc   33.37 %
Arcutis Biotherapeutics Inc   32.92 %
Caredx Inc   32.81 %
Zevra Therapeutics Inc   32.56 %
Acadia Pharmaceuticals Inc   32.39 %
Pro dex Inc   31.96 %
Protalix Biotherapeutics inc   31.61 %
Illumina Inc   31.08 %

Date modified: 2026-08-18T07:46:10+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.